Analyst Ratings For AstraZeneca plc (LON:AZN)
Today, HSBC reiterated its Reduce rating on AstraZeneca plc (LON:AZN).
There are 9 Buy Ratings, 6 Hold Ratings, 3 Sell Ratings, no Strong Buy Ratings on the stock.
The current consensus rating on AstraZeneca plc (LON:AZN) is Hold with a consensus target price of GBX 7,062.50 per share, a potential .
Some recent analyst ratings include
- 10/1/2019-AstraZeneca plc (LON:AZN) had its Reduce rating reiterated by HSBC
- 9/30/2019-AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Shore Capital
- 9/30/2019-AstraZeneca plc (LON:AZN) had its Sell rating reiterated by UBS Group
- 9/30/2019-AstraZeneca plc (LON:AZN) had its Buy rating reiterated by Deutsche Bank with a GBX 7,800 price target
- 9/20/2019-AstraZeneca plc (LON:AZN) had its Hold rating reiterated by Liberum Capital
Recent Trading Activity for AstraZeneca plc (LON:AZN)
Shares of AstraZeneca plc closed the previous trading session at 7,181.00 −80.00 1.10% with 44.78 shares trading hands.
